Introduction Rare tumours called pancreatic neuroendocrine tumours (PNETs) develop in the pancreatic islet cells. Significant improvements in patient outcomes and a wider range of therapeutic choices have been made throughout time in the diagnosis and treatment of PNETs. The management of pancreatic neuroendocrine tumours has undergone a radical change as a result of some of the noteworthy...